Dr Deniz Tschammler > McDermott Will & Emery Rechtsanwälte Steuerberater LLP > Munich, Germany > Lawyer Profile

McDermott Will & Emery Rechtsanwälte Steuerberater LLP
NYMPHENBURGER STRASSE 3
80355 MUNICH
Germany
Deniz Tschammler photo

Work Department

Health Industry Advisory

Position

Deniz specializes on complex legal, commercial and strategic projects in the health and life sciences sector. He advises on transactions and collaborations, disputes in and out of court, market entry and reimbursement pathways, as well as data protection and other compliance challenges of an increasingly digitized industry. His clients involve global pharmaceutical companies and medical device manufacturers, early stage companies with a focus on innovative health products and disruptive business models, as well as investors in German and European health markets.

Languages

English, German

Education

University of St. Gallen, Executive MBA, 2021
King’s College London, LLM, 2013
Higher Regional Court of Wiesbaden, Second State Examination, 2012
Philipps University of Marburg, PhD, 2011
Goethe University of Frankfurt, First State Examination, 2008
Universities of Frankfurt and Lyon, Diploma in French Law, 2007

Lawyer Rankings

Germany > Industry focus > Healthcare and life sciences

(Next Generation Partners)

Deniz TschammlerMcDermott Will & Emery Rechtsanwälte Steuerberater LLP

McDermott Will & Emery Rechtsanwälte Steuerberater LLP‘s advisory offering focuses on three segments: project support (transactions and cooperations), regulation (market entry and licensing) and digitisation. The latter frequently pertains to the development of healthcare apps and databases, including interfacing data protection matters, a key contact here is Deniz Tschammler. Among the client roster are pharmaceutical, medical technology and biotechnology companies; the advice to healthcare funds on transactions and venture capital financing is a recent growth area. Practice head Stephan Rau specialises in M&A transactions as well as regulatory and compliance issues. He is supported by Monika Emilia Richter (implementation and advice on strategic cooperations, licensing, development agreements) and Jana Grieb, who advises pharmaceutical and medical technology companies on various issues, including research and development-related issues as well as market entry, advertising and sales. M&A expert Nadine Hartung joined Raue in March 2023.